Contact
PD Dr. med Claudia Schrimpf
Our department participates in various clinical trials and is conducting a variety of studies by ourselves to continuously improve the treatment of our patients.
Title: Eagle – Endurant for Challenging Anatomy: Global Experience Registry – EVAR treatment with the Endurant Stent Graft of challenging anatomy in experienced hands, the real world experience
Content: Multi-centric, non-interventional, non-randomised, single-arm, prospective registry for collecting further information on the clinical functionality and performance of the endurant stent prosthesis in a large patient population (250 patients) with difficult anatomical conditions. The patient follow-up period is five years.
Inclusion criteria: All patients with abdominal aortic aneurysm
PI: Prof. Dr. med. Alexander Zimmermann
Status: open
Go to websiteTitle: Great – Globales Register für Endovaskuläre Aortentherapie
Content: Multi-centric, non-interventional, non-randomised, single-arm, prospective registry for collecting data on the clinical functionality and performance of the Gore stent prosthesis in a large patient population (500 patients). The follow-up period of the patients is five years.
Inclusion criteria: All patients with abdominal aortic aneurysm
PI: Prof. Dr. med. Alexander Zimmermann
Status: open
Go to websiteTitle: Horizon FIM Study – A prospective, open-label, non randomized, single-arm, First-in-Man Clinical Study to evaluate the safety and performance of the HORIZON™ Abdominal Aortic Aneurysm Stent Graft System
Content: First-in-man, prospective, single-arm, non-randomised clinical trial assesing the functionality of the HORIZON™ Abdominal Aortic Aneurysm (AAA) Stent-Graft System”. The follow-up period of the patients is two years.
Inclusion criteria: All patients with abdominal aortic aneurysm
PI: Prof. Dr. med. Alexander Zimmermann
Status: finished
Title: Horizon 2 – A prospective, open-label, non-randomized, pivotal study to evaluate the safety and performance of the Horizon™ Abdominal Aortic Aneurysm (AAA) Stent graft System
Content: Multi-centric, prospective, open-label, non-randomised, single-arm, CE pivotal study assessing the safety and functionality of the Horizon™ Abdominal Aortic Aneurysm (AAA) Stent-Graft System for the treatment of infrarenal abdominal aortic and/or aorto-iliac aneurysm. The follow-up period of the patients is five years.
Inclusion criteria: All patients with abdominal aortic aneurysm
PI: Prof. Dr. med. Alexander Zimmermann
Status: Inclusion phase completed
Title: Vascular graft cohort study (VASGRA)
Content: A prospective registry of vascular surgery patients to evaluate risk factors for graft infection
Inclusion criteria: All patients who have received an implantation of vascular grafts
PI: PD Dr. med. Barbara Hasse
Status: open
Go to website